Maternal docosahexaenoic acid supplementation for neurodevelopmental outcomes of breastfed very preterm infants: a follow-up at 5 years’ corrected age of a randomized clinical trial (MOBYDIckPS)
Monday, May 6, 2024
1:15 PM – 1:30 PM ET
Location: Metro Toronto Convention Centre: 104 CD
Publication Number: 3055.2
Sara-Pier Paquet, Faculty of Medicine Université Laval, Québec, PQ, Canada; Etienne Pronovost, CHU de Québec-Université Laval, Quebec, PQ, Canada; David Simonyan, CHU de Québec, Québec, PQ, Canada; Georges Caouette, CHU de Quebec-Université Lavsl, Quebec City, PQ, Canada; Célia Matte-Gagné, Laval University, Quebec, PQ, Canada; Francois Olivier, Montreal Children's Hospital, McGill University Health Center, Montréal, PQ, Canada; Alyssa Morin, Universite de Sherbrooke Faculty of Medicine, Sherbrooke, PQ, Canada; Ibrahim Mohamed, Universite de Montreal Faculty of Medicine, Montreal, PQ, Canada; Isabelle Marc, Faculty of Medicine Université Laval, Quebec, PQ, Canada; Mireille Guillot, Faculty of Medicine Université Laval, Saint-Augustin-de-Desmaures, PQ, Canada
Presenting Author(s)
Sara-Pier Paquet, MSc (she/her/hers)
student Faculty of Medicine Université Laval Québec, Quebec, Canada